Comparison of drug adherence rates among patients with seven different medical conditions

被引:454
作者
Briesacher, Becky A. [1 ,3 ]
Andrade, Susan E. [2 ,3 ]
Fouayzi, Hassan [3 ]
Chan, Arnold [4 ]
机构
[1] Univ Massachusetts, Sch Med, Div Geriatr Med, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA
[3] Meyers Primary Care Inst, Worcester, MA USA
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
来源
PHARMACOTHERAPY | 2008年 / 28卷 / 04期
关键词
drug adherence; comparative study; type 2 diabetes mellitus; hypertension; osteoporosis; hypercholesterolemia; gout; hypothyroidism; seizure disorders;
D O I
10.1592/phco.28.4.437
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To compare drug adherence rates among patients with gout, hypercholesterolemia, hypertension, hypothyroidism, osteoporosis, seizure disorders, and type 2 diabetes mellitus by using a standardized approach. Design. Longitudinal study Data Source. Health care claims data from 2001-2004. Patients. A total of 706,032 adults aged 18 years or older with at least one of the seven medical conditions and with incident use of drug therapy for that condition. Measurements and Main Results. Drug adherence was measured as the sum of the days' supply of drug therapy over the first year observed. Covariates were age, sex, geographic residence, type of health plan, and a comorbidity score calculated by using the Hierarchical Condition Categories risk adjuster. Bivariate statistics and stratification analyses were used to assess unadjusted means and frequency distributions. Sample sizes ranged from 4984 subjects for seizure disorders to 457,395 for hypertension. During the first year of drug therapy, 72.3% of individuals with hypertension achieved adherence rates of 80% or better compared with 68.4%, 65.4%, 60.8%, 54.6%, 51.2%, or 36.8% for those with hypothyroidism, type 2 diabetes, seizure disorders, hypercholesterolemia, osteoporosis, or gout, respectively. Age younger than 60 years was associated with lower adherence across all diseases except seizure disorders. Comorbidity burden and adherence varied by disease. As comorbidity increased, adherence among subjects with osteoporosis decreased, whereas adherence among those with hypertension, hypercholesterolemia, or gout increased. Add-on drug therapies and previous experience with taking drugs for the condition increased adherence among subjects with hypertension, type 2 diabetes, hypothyroidism, or seizure disorders but not the other conditions. Conclusion. This uniform comparison of drug adherence revealed modest variation across six of seven diseases, with the outlier condition being gout.
引用
收藏
页码:437 / 443
页数:7
相关论文
共 10 条
  • [1] ANDRADE SE, 1965, DRUG SAFETY, V15, P575
  • [2] Methods for evaluation of medication adherence and persistence using automated databases
    Andrade, Susan E.
    Kahler, Kristijan H.
    Frech, Feride
    Chan, K. Arnold
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (08) : 565 - 574
  • [3] Ash AS, 2000, HEALTH CARE FINANC R, V21, P7
  • [4] Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs
    Briesacher, B
    Kamal-Bahl, S
    Hochberg, M
    Orwig, D
    Kahler, KH
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (15) : 1679 - 1684
  • [5] Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
    Brookhart, M. Alan
    Patrick, Amanda R.
    Dormuth, Colin
    Avorn, Jerry
    Shrank, William
    Cadarette, Suzanne M.
    Solomon, Daniel H.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 166 (03) : 348 - 354
  • [6] Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy
    Choo, PW
    Rand, CS
    Inui, TS
    Lee, MLT
    Cain, E
    Cordeiro-Breault, M
    Canning, C
    Platt, R
    [J]. MEDICAL CARE, 1999, 37 (09) : 846 - 857
  • [7] Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures
    Hess, Lisa M.
    Raebel, Marsha A.
    Conner, Douglas A.
    Malone, Daniel C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (7-8) : 1280 - 1288
  • [8] Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus
    Ho, P. Michael
    Rumsfeld, John S.
    Masoudi, Frederick A.
    McClure, David L.
    Plomondon, Mary E.
    Steiner, John F.
    Magid, David J.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (17) : 1836 - 1841
  • [9] Compliance with osteoporosis medications
    Solomon, DH
    Avorn, J
    Katz, JN
    Finkelstein, JS
    Arnold, M
    Polinski, JM
    Brookhart, MA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (20) : 2414 - 2419
  • [10] Zhao Y, 2001, Health Serv Res, V36, P180